ALLMedicine™ C-terminal Telopeptide Center
Research & Reviews 367 results
https://doi.org/10.1111/cen.14496
Clinical Endocrinology; Duan X, Yang Y et. al.
May 7th, 2021 - Bone responsiveness to parathyroid hormone (PTH) in different subtypes of pseudohypoparathyroidism type 1 (PHP1) remains controversial. We aimed to investigate this phenomenon using bone turnover markers (BTMs) in a large cohort of PHP1 patients. ...
https://doi.org/10.2340/16501977-2835
Journal of Rehabilitation Medicine; Waluyo Y, Budu et. al.
Apr 27th, 2021 - To assess the effects of dextrose prolotherapy in patients with knee osteoarthritis on the levels of serum cartilage oligomeric proteinase and urinary C-terminal telopeptide of type II collagen, and on the Western Ontario McMaster Universities Ind...
https://doi.org/10.1002/jbmr.4305
Journal of Bone and Mineral Research : the Official Journ... Sølling AS, Harsløf T et. al.
Apr 4th, 2021 - Increased bone turnover and rapid bone loss follow discontinuation of denosumab. We investigated the long-term efficacy of zoledronate (ZOL) in maintaining bone mineral density (BMD) after discontinuation of denosumab. In this randomized, open-lab...
https://doi.org/10.1007/s00223-021-00816-5 10.1515/CCLM.2011.602 10.1007/s00198-017-3906-6 10.1007/s12325-019-01063-9 10.1007/s00198-020-05310-6 10.1515/cclm-2019-0174 10.1016/j.clinbiochem.2015.03.002 10.1007/s00198-020-05362-8 10.2307/2532051 10.1016/j.cca.2016.06.036 10.1007/s00198-017-4082-4 10.1093/clinchem/44.11.2281 10.1016/j.bone.2012.02.003 10.1515/cclm-2015-0162 10.1515/cclm-2013-0934 10.1007/s00198-017-4026-z 10.1016/j.cccn.2004.07.024 10.1093/clinchem/47.5.939 10.1515/cclm-2014-1249 10.1515/cclm-2015-0923 10.1016/j.clinbiochem.2012.03.035
Calcified Tissue International; Cavalier E, Eastell R et. al.
Mar 4th, 2021 - Biochemical bone turnover markers are useful tools to assess bone remodeling. C-terminal telopeptide of type I collagen (ß-CTX) has been recommended as a reference marker for bone resorption in research studies. We describe the results of a multic...
https://doi.org/10.1016/j.jocd.2020.11.002
Journal of Clinical Densitometry : the Official Journal O... Slouma M, Aissaoui T et. al.
Dec 8th, 2020 - Mechanisms underlying bone fragility in patients under dialysis are various. The assessment of bone disorder is not yet codified in these patients. Our study aimed to determine the relationship between the serum fibroblast growth factor 23 (FGF23)...
Clinicaltrials.gov 369 results
https://doi.org/10.1111/cen.14496
Clinical Endocrinology; Duan X, Yang Y et. al.
May 7th, 2021 - Bone responsiveness to parathyroid hormone (PTH) in different subtypes of pseudohypoparathyroidism type 1 (PHP1) remains controversial. We aimed to investigate this phenomenon using bone turnover markers (BTMs) in a large cohort of PHP1 patients. ...
https://doi.org/10.2340/16501977-2835
Journal of Rehabilitation Medicine; Waluyo Y, Budu et. al.
Apr 27th, 2021 - To assess the effects of dextrose prolotherapy in patients with knee osteoarthritis on the levels of serum cartilage oligomeric proteinase and urinary C-terminal telopeptide of type II collagen, and on the Western Ontario McMaster Universities Ind...
https://doi.org/10.1002/jbmr.4305
Journal of Bone and Mineral Research : the Official Journ... Sølling AS, Harsløf T et. al.
Apr 4th, 2021 - Increased bone turnover and rapid bone loss follow discontinuation of denosumab. We investigated the long-term efficacy of zoledronate (ZOL) in maintaining bone mineral density (BMD) after discontinuation of denosumab. In this randomized, open-lab...
https://doi.org/10.1007/s00223-021-00816-5 10.1515/CCLM.2011.602 10.1007/s00198-017-3906-6 10.1007/s12325-019-01063-9 10.1007/s00198-020-05310-6 10.1515/cclm-2019-0174 10.1016/j.clinbiochem.2015.03.002 10.1007/s00198-020-05362-8 10.2307/2532051 10.1016/j.cca.2016.06.036 10.1007/s00198-017-4082-4 10.1093/clinchem/44.11.2281 10.1016/j.bone.2012.02.003 10.1515/cclm-2015-0162 10.1515/cclm-2013-0934 10.1007/s00198-017-4026-z 10.1016/j.cccn.2004.07.024 10.1093/clinchem/47.5.939 10.1515/cclm-2014-1249 10.1515/cclm-2015-0923 10.1016/j.clinbiochem.2012.03.035
Calcified Tissue International; Cavalier E, Eastell R et. al.
Mar 4th, 2021 - Biochemical bone turnover markers are useful tools to assess bone remodeling. C-terminal telopeptide of type I collagen (ß-CTX) has been recommended as a reference marker for bone resorption in research studies. We describe the results of a multic...
https://doi.org/10.1016/j.jocd.2020.11.002
Journal of Clinical Densitometry : the Official Journal O... Slouma M, Aissaoui T et. al.
Dec 8th, 2020 - Mechanisms underlying bone fragility in patients under dialysis are various. The assessment of bone disorder is not yet codified in these patients. Our study aimed to determine the relationship between the serum fibroblast growth factor 23 (FGF23)...
News 1 results
https://www.medpagetoday.com/obgyn/menopause/33705
Jul 11th, 2012 - Action Points In a study of post-menopausal women, a relatively short interval of abstinence from moderate alcohol consumption resulted in increased serum levels of the biochemical markers of bone formation and bone resorption. Note that within 12...
